SNAP-8

SNAP-8, commonly identified as acetyl octapeptide-3, is studied primarily in topical cosmetic and cellular models involving SNARE-complex-related neurotransmitter release and expression-line appearance.

Designed as a peptide fragment intended to interfere with formation or function of the SNARE complex in superficial experimental systems.

Limited topical/cosmetic evidence; systemic evidence is lacking.

Level III, Limited topical evidence

Results are formulation- and delivery-dependent. Cosmetic studies do not establish systemic pharmacology or injectable safety.

Potential concerns include irritation, sensitization, uncertain systemic effects, and product-identity or contamination issues.

Cosmetic research ingredient; no FDA-approved injectable drug product.

Supplied strictly for in-vitro and ex-vivo laboratory research. Not for human or veterinary administration, diagnostic, or therapeutic use. Import and regulatory compliance remain the responsibility of the receiving researcher.

• SNAP-8 (Acetyl Octapeptide-3), 10 mgLyophilized

Every Cendrix lot ships with an HPLC purity chromatogram, mass-spectrometry identity confirmation, appearance and reconstitution observations, and endotoxin testing where applicable. Lot certificates are retrievable from the Quality page using the lot number printed on the vial.

External searches link to PubMed, ClinicalTrials.gov, Google Scholar, and FDA records. Cendrix does not endorse interpretations published in third-party sources.